Skip to content
GoCo Health Innovation City enters exciting next phase with approved development plan and new CEO

Press release -

GoCo Health Innovation City enters exciting next phase with approved development plan and new CEO

GoCo Health Innovation City enters exciting next phase with approved development plan and new CEO

Today, the vision of GoCo Health Innovation City took another step closer to becoming reality. With a recently approved development plan supported by the city of Mölndal, and a formal partnership between Next Step, Vectura, and AstraZeneca in place, GoCo Health Innovation City welcomed hundreds of participants to a launch event held today at the development site. Attendees learned about the new brand name, as well as what the ambitious project initiative aims to deliver.

“We are at an exciting crossroads right now in Sweden, in which we have the potential to be a true global leader in life science. The political will is there, and we already have numerous forward-thinking companies, organisations, and individuals based in Sweden,” said Matti Ahlqvist, AstraZeneca Gothenburg Site Director. “To take us to the next level, we need to create space for these different companies and perspectives to come together to collaborate and unlock new innovative ideas. That is exactly what GoCo Health Innovation City will do.”

GoCo Health Innovation City formally replaces prior names for the planned development site in Mölndal. As the name suggests, GoCo Health Innovation City has invited forward-thinking health companies, entrepreneurs, start-ups, academic experts, and designers to co-locate and collaborate. The GoCo Health Innovation City land will include the current AstraZeneca R&D site, as well as new buildings for new tenants. Opening in 2021, the first new building, designed by architectural partners Semrén & Månsson, will include a modular sustainable structure equipped with cutting-edge digital technology and collaborative environments.

As announced at today’s event, GoCo Health Innovation City is also very pleased to welcome Peder Wahlgren as CEO of the joint venture. With more than 30 years in the real estate development industry, including 20 years at Wallenstram, Peder Wahlgren will be an important addition and key player as the project's implementation phase takes off.

Speaking of the joint partnership, Peder said:

“It feels wonderful to have one of the world's leading life-science companies on board with their experience and expertise, all of which adds further power to the joint partnership between Next Step and Vectura. This also applies to the city of Mölndal, which is a forward-looking and action-oriented municipality.”

For more information, contact:

Peder Wahlgren

CEO in the joint venture between Next Step/Vectura Fastigheter

0705 17 11 47

Related links


Vi utvecklar GoCo Health Innovation City, ett helt nytt grannskap i befintligt hälso-kluster i Göteborgsregionen, med nya innovativa miljöer och mötesplatser som ska locka forskare, entreprenörer och lovande talanger från hela världen till Sverige och närmare bestämt Västsverige


Moa Dicksdotter

Moa Dicksdotter

Press contact Head of Community 0768-98 83 01
Josefine Magnusson

Josefine Magnusson

Press contact marknadskoordinator 0721933501
Josephine Urbath Söderström

Josephine Urbath Söderström

Press contact Marketing Communications Project Manager Marknad och Kommunikation +46 768 99 27 70

The new world for life science

GoCo Health Innovation City är en miljardsatsning på nya forsknings- och utvecklingsmiljöer i
anslutning till AstraZenecas anläggning i Mölndal. Visionen är att skapa en plats med potential
att ta ett globalt ledarskap inom Life Science. Projektet har initierats av företagen Next Step,
Vectura Fastigheter och AstraZeneca.

GoCo Health Innovation City
Kärragatan 5
43153 Mölndal